Description:
OSTEOGENESIS IMPERFECTA, TYPE II; OI2
COLLAGEN, TYPE I, ALPHA-2; COL1A2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Connective Tissue, Muscle, and Bone |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
4 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
COL1A2 |
Chromosomal Location |
7q21.3 |
Allelic Variant 1 |
120160.0008; OSTEOGENESIS IMPERFECTA, TYPE II |
Identified Mutation |
GLY907ASP; In an infant with a lethal variety of OI, Baldwin et al [J. Biol. Chem. 264: 3002 (1989)] found a G-to-A change that converted glycine-907- to aspartic acid. The change resulted in decreased thermal stability of type I collagen synthesized by the patient's fibroblasts. |
Remarks |
Line JIMM-69; about half of pro-a chains are post-translationally overmodified & have a decreased thermal stability; a2 (I) chain has a single base substitution of A for G that converted an Asp for a Gly at amino position 907 [Gly907Asp (G907D)]; negative family history |
Baldwin CT, Constantinou CD, Dumars KW, Prockop DJ, A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix. J Biol Chem264:3002-6 1989 |
PubMed ID: 2914942 |
Passage Frozen |
4 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
8% |
Medium |
Dulbecco Modified Eagles Medium (high glucose) with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|